Toren A - Search Results

1

MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells.

Rozenfeld-Granot G, Toren A, Amariglio N, Nagler A, Rosenthal E, Biniaminov M, Brok-Simoni F, Rechavi G. Rozenfeld-Granot G, et al. Among authors: toren a. Exp Hematol. 2002 May;30(5):473-80. doi: 10.1016/s0301-472x(02)00786-5. Exp Hematol. 2002. PMID: 12031654 Free article.

2

Lack of bcr rearrangement in juvenile chronic myeloid leukemia.

Toren A, Mandel M, Amariglio N, Hakim Y, Brok-Simoni F, Rechavi G, Neumann Y, Ramot B. Toren A, et al. Med Pediatr Oncol. 1991;19(6):493-5. doi: 10.1002/mpo.2950190608. Med Pediatr Oncol. 1991. PMID: 1683680

3

Translocation (2;14)(p13;q32) in CD10+ ;CD13+ acute lymphatic leukemia.

Berkowicz M, Toren A, Rosner E, Biniaminov M, Rosenthal E, Gipsh N, Berman S, Hardan I, Mandel M, Amariglio N, et al. Berkowicz M, et al. Among authors: toren a. Cancer Genet Cytogenet. 1995 Sep;83(2):140-3. doi: 10.1016/0165-4608(95)00038-q. Cancer Genet Cytogenet. 1995. PMID: 7553584

4

Genetic predisposition and cyclophosphamide treatment in a girl with bladder carcinoma?

Kenet G, Mandel M, Mor Y, Toren A, Jonas P, Kende G, Rechavi G, Neumann Y. Kenet G, et al. Among authors: toren a. Med Pediatr Oncol. 1995 Apr;24(4):269-70. doi: 10.1002/mpo.2950240411. Med Pediatr Oncol. 1995. PMID: 7700174

5

Familial leukemia: description of two kindreds and a review of the genetic aspects of the disease.

Kende G, Toren A, Mandel M, Neumann Y, Kenet G, Brok-Simoni F, Ramot B, Ben-Bassat I, Rechavi G. Kende G, et al. Among authors: toren a. Acta Haematol. 1994;92(4):208-11. doi: 10.1159/000204222. Acta Haematol. 1994. PMID: 7701920

6

Rearrangement of the immunoglobulin heavy chain gene in juvenile chronic myeloid leukaemia.

Mark Z, Toren A, Amariglio N, Vonsover A, Rechavi G, Brok-Simoni F. Mark Z, et al. Among authors: toren a. Br J Haematol. 1995 Jun;90(2):353-7. doi: 10.1111/j.1365-2141.1995.tb05158.x. Br J Haematol. 1995. PMID: 7794756

7

Congenital haemolytic anaemia associated with adenylate kinase deficiency.

Toren A, Brok-Simoni F, Ben-Bassat I, Holtzman F, Mandel M, Neumann Y, Ramot B, Rechavi G, Kende G. Toren A, et al. Br J Haematol. 1994 Jun;87(2):376-80. doi: 10.1111/j.1365-2141.1994.tb04925.x. Br J Haematol. 1994. PMID: 7947281

8

Lymphomatous T-cell leukemia in two Arab children. Is there a role for an environmental effect.

Berkowicz M, Toren A, Rosner E, Mandel M, Vonsover A, Biniaminov M, Amariglio N, Mark Z, Kenet G, Neumann Y, et al. Berkowicz M, et al. Among authors: toren a. Leukemia. 1994 Nov;8(11):1995-8. Leukemia. 1994. PMID: 7967744

9

The anti-apoptotic role of infectious agents in lymphoid malignancies characterized by c-myc deregulation.

Toren A, Rechavi G. Toren A, et al. Br J Haematol. 1994 Aug;87(4):675-7. doi: 10.1111/j.1365-2141.1994.tb06722.x. Br J Haematol. 1994. PMID: 7986705 Review. No abstract available.

10

Primary central nervous system Burkitt's lymphoma presenting as Guillain-Barré syndrome.

Toren A, Mandel M, Shahar E, Rimmoni E, Roizin H, Neuman Y, Brok-Simoni F, Mark Z, Biniaminov M, Rosenthal E, et al. Toren A, et al. Med Pediatr Oncol. 1994;23(4):372-5. doi: 10.1002/mpo.2950230410. Med Pediatr Oncol. 1994. PMID: 8058010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters